A new study of over 3500 patients with overactive thyroids shows that elderly patients experience fewer signs and symptoms of the condition. This study, which will be presented at the annual Society for Endocrinology BES meeting in Harrogate, is the largest study to date to show a difference in symptoms...
A new testosterone patch, designed to pep up a woman’s flagging sex drive after womb and ovary removal, may not work, and its long term safety is not proven, says Drug and Therapeutics Bulletin (DTB). Intrinsa was recently licensed in the UK for the treatment of women, who have gone through the...
A study in mice indicates that overeating, rather than the obesity it causes, is the trigger for developing metabolic syndrome, a collection of heath risk factors that increases an individual’s chances of developing insulin resistance, fatty liver, heart disease and type 2 diabetes. How and where...
Gov. Rick Perry has announced the awarding of a $5.5 million grant to the University of Houston through the Texas Emerging Technology Fund (ETF). As a result of the ETF grant, UH has recruited a top hormones researcher and his team to carry out laboratory research and to create next-generation pharmaceuticals...
A new Rice University study published in the Journal of Neuroscience found that socioemotional meanings, including sexual ones, are conveyed in human sweat. Denise Chen, assistant professor of psychology at Rice, looked at how the brains of female volunteers processed and encoded the smell of sexual...
Bionovo, Inc. (Nasdaq: BNVI) announced results describing predictable estrogen regulatory elements that can be used to identify estrogenic drugs that are safer. The data, published in Molecular and Cellular Endocrinology, showed that the new regulatory elements can distinguish the estrogenic pharmacological...
Arete Therapeutics Inc. announced positive top line Phase I results for AR9281, an orally-administered soluble epoxide hydrolase (s-EH) inhibitor for the treatment of metabolic syndrome. The results of the multi-dose study demonstrate that AR9281 was safe and well tolerated in healthy volunteers. “We...
A research team led by Mitchell Lazar, MD, PhD, Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine, has discovered a key molecular partnership that coordinates body rhythms and metabolism. Lazar and his colleagues, including the study’s...
For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol. A new UVA Health...
For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol. A new UVA Health...
